Summary
Takaaki Mizuno is a physician-scientist and founder-CEO transforming Japanese oncology data into decision-ready evidence through CLINIAL, blending clinician tacit knowledge with AI to improve trial design and drug development. With eight years’ focused experience in Phase I oncology at a top global early-phase center and leadership of 100+ first-in-human trials, he brings rare hands-on trial expertise plus PMDA negotiation and regulatory strategy. He concurrently leads cancer genomic decision-making as a Specially Appointed Assistant Professor at Keio University and advises industry and regulators, bridging bedside insight, bioinformatics pattern recognition, and translational research. Active in national cancer-policy groups and professional societies, he combines academic rigor (M.D., Ph.D.) with a startup builder’s pragmatism to unlock high-quality clinical data that volume-driven platforms miss.
7 years of coding experience
Doctor of Philosophy - PhD, Medicine, Fast Track Graduation, Doctor of Philosophy - PhD, Medicine, Fast Track Graduation at The Jikei University School of Medicine
Doctor of Medicine - MD, Doctor of Medicine - MD at Nagoya City University